Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MVAp53 |
Trade Name | |
Synonyms | p53MVA |
Drug Descriptions |
MVAp53 is a modified vaccinia virus Ankara-based vaccine that may induce a T-cell mediated immune response against p53-expressing tumor cells (PMID: 21843052, PMID: 30094792). |
DrugClasses | p53 Vaccine 5 |
CAS Registry Number | NA |
NCIT ID | C116868 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Gemcitabine + MVAp53 | Gemcitabine MVAp53 | 0 | 0 |
MVAp53 | MVAp53 | 1 | 1 |
MVAp53 + Pembrolizumab | MVAp53 Pembrolizumab | 0 | 2 |